These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
100 related articles for article (PubMed ID: 22339679)
21. Emergence and spread of antibiotic-resistant Gram-positive bacterial pathogens. Witte W; Cuny C; Klare I; Nübel U; Strommenger B; Werner G Int J Med Microbiol; 2008 Jul; 298(5-6):365-77. PubMed ID: 18325835 [TBL] [Abstract][Full Text] [Related]
22. In vitro ciprofloxacin resistance patterns of gram-positive bacteria isolated from clinical specimens in a teaching hospital in Saudi Arabia. Akhtar N; Alzahrani A; Obeid Oel-T; Dassal D J Ayub Med Coll Abbottabad; 2009; 21(3):54-6. PubMed ID: 20929013 [TBL] [Abstract][Full Text] [Related]
23. An overview of antimicrobial susceptibility patterns of gram-positive bacteria from National Antimicrobial Resistance Surveillance Thailand (NARST) program from 2000 to 2005. Mootsikapun P; Trakulsomboon S; Sawanpanyalert P; Aswapokee N; Suankratay C J Med Assoc Thai; 2009 Aug; 92 Suppl 4():S87-90. PubMed ID: 21294504 [TBL] [Abstract][Full Text] [Related]
24. Antimicrobial resistance in Europe and its potential impact on empirical therapy. Rossolini GM; Mantengoli E Clin Microbiol Infect; 2008 Dec; 14 Suppl 6():2-8. PubMed ID: 19040461 [TBL] [Abstract][Full Text] [Related]
25. Risk factors and etiology of neonatal sepsis in Tikur Anbessa University Hospital, Ethiopia. Shitaye D; Asrat D; Woldeamanuel Y; Worku B Ethiop Med J; 2010 Jan; 48(1):11-21. PubMed ID: 20607993 [TBL] [Abstract][Full Text] [Related]
26. In vitro activity of tigecycline against 6792 Gram-negative and Gram-positive clinical isolates from the global Tigecycline Evaluation and Surveillance Trial (TEST Program, 2004). Hoban DJ; Bouchillon SK; Johnson BM; Johnson JL; Dowzicky MJ; Diagn Microbiol Infect Dis; 2005 Jul; 52(3):215-27. PubMed ID: 16105567 [TBL] [Abstract][Full Text] [Related]
28. Reversal of resistance in microorganisms by help of non-antibiotics. Kristiansen JE; Hendricks O; Delvin T; Butterworth TS; Aagaard L; Christensen JB; Flores VC; Keyzer H J Antimicrob Chemother; 2007 Jun; 59(6):1271-9. PubMed ID: 17403708 [TBL] [Abstract][Full Text] [Related]
29. [Role of daptomycin in the empirical and directed therapy of infections caused by Gram-positive bacteria in the critically ill patient]. Garnacho-Montero J; Amaya-Villar R; Gómez-Grande ML; Jerez V; Lorente-Ramos L; Loza A; Martínez A; Pozo JC; Sierra R; Pomares J; de la Torre MV; Ortiz C Rev Esp Quimioter; 2011 Mar; 24(1):13-24. PubMed ID: 21412665 [TBL] [Abstract][Full Text] [Related]
30. Antimicrobial activity and spectrum of daptomycin: results from the surveillance program in Australia and New Zealand (2008). Bell JM; Turnidge JD; Sader HS; Jones RN Pathology; 2010; 42(5):470-3. PubMed ID: 20632825 [TBL] [Abstract][Full Text] [Related]
31. Tigecycline: first of a new class of antimicrobial agents. Rose WE; Rybak MJ Pharmacotherapy; 2006 Aug; 26(8):1099-110. PubMed ID: 16863487 [TBL] [Abstract][Full Text] [Related]
32. [Surveillance of antimicrobial resistance of bacteria isolated from bloodstream infections: data of the French National Observatory for Epidemiology of Bacterial Resistance to Antibiotics (ONERBA), 1998-2003]. Bertrand X; Costa Y; Pina P Med Mal Infect; 2005 Jun; 35(6):329-34. PubMed ID: 16039819 [TBL] [Abstract][Full Text] [Related]
33. Antimicrobial susceptibility of Gram-positive bacterial isolates from the Asia-Pacific region and an in vitro evaluation of the bactericidal activity of daptomycin, vancomycin, and teicoplanin: a SENTRY Program Report (2003-2004). Biedenbach DJ; Bell JM; Sader HS; Fritsche TR; Jones RN; Turnidge JD Int J Antimicrob Agents; 2007 Aug; 30(2):143-9. PubMed ID: 17531446 [TBL] [Abstract][Full Text] [Related]
34. Potential role of the cardiovascular non-antibiotic (helper compound) amlodipine in the treatment of microbial infections: scope and hope for the future. Mazumdar K; Asok Kumar K; Dutta NK Int J Antimicrob Agents; 2010 Oct; 36(4):295-302. PubMed ID: 20591629 [TBL] [Abstract][Full Text] [Related]
35. Activity of daptomycin against multi-resistant Gram-positive bacteria including enterococci and Staphylococcus aureus resistant to linezolid. Johnson AP; Mushtaq S; Warner M; Livermore DM Int J Antimicrob Agents; 2004 Oct; 24(4):315-9. PubMed ID: 15380254 [TBL] [Abstract][Full Text] [Related]
36. Effects of azelastine nasal spray on nasal and nasopharyngeal microflora. Aksoy F; Senturk E; Doğan R; Veyseller B; Ozturan O; Gönüllü N; Yilmaz F J Laryngol Otol; 2016 Jan; 130(1):95-9. PubMed ID: 26515526 [TBL] [Abstract][Full Text] [Related]
37. A forward chemical screen identifies antibiotic adjuvants in Escherichia coli. Taylor PL; Rossi L; De Pascale G; Wright GD ACS Chem Biol; 2012 Sep; 7(9):1547-55. PubMed ID: 22698393 [TBL] [Abstract][Full Text] [Related]